Previous Close | 13.88 |
Open | 13.52 |
Bid | 13.85 x 200 |
Ask | 17.34 x 200 |
Day's Range | 13.52 - 14.18 |
52 Week Range | 10.62 - 18.44 |
Volume | |
Avg. Volume | 78,744 |
Market Cap | 478.703M |
Beta (5Y Monthly) | -0.50 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Entrada Therapeutics ( NASDAQ:TRDA ) First Quarter 2024 Results Key Financial Results Revenue: US$59.1m (up 134% from...
Director Peter Kim of Entrada Therapeutics Inc (NASDAQ:TRDA) has recently increased his stake in the company.
The analysts covering Entrada Therapeutics, Inc. ( NASDAQ:TRDA ) delivered a dose of negativity to shareholders today...